Low- and middle-income countries that hosted completed COVID-19 vaccine trials received disproportionately fewer doses than high-income counterparts; mental health apps indicated to increase uptake in underserved men; CDC report finds notable stillbirth risk in pregnant women with COVID-19.
Despite hosting some of the clinical trials that led to the approval for several COVID-19 vaccines, low- and middle-income countries where the trials were held received disproportionately less doses than high-income counterparts, according to findings of a study published last week in JAMA Network Open. Reported by CIDRAP, a median of 15.4%, 48.8%, and 78.8% of doses of vaccines were sent to low-, lower-middle-, and upper-middle-income countries that hosted completed trials through the COVAX initiative, which is intended to provide equitable access to COVID-19 tests, treatments, and vaccines worldwide. Recently, World Health Organization Director-General Tedros Adhanom Ghebreyesus said it was unacceptable that vaccine manufacturers had overwhelmingly supplied rich countries at the highest prices.
As reported by The Washington Post, mental health apps have become important resources for men experiencing mental health issues, who have been shown in prior research to seek out help at approximately half the rate of women and are 4 times more likely to die of suicide than their female counterparts. With studies attributing gender expectations of not appearing vulnerable or unable to handle one’s own problems as reasons for men avoiding help, online help was noted to be a less intimidating and private entry to mental health for male populations. The 2 meditation-focused apps Headspace and Calm currently account for 90% of all active mental health/well-being app users, whereas other apps such as Tethr are designed for men or have men-specific sections.
According to a CDC Morbidity and Mortality Weekly Report published last Friday, stillbirths were found to occur in about 1 in 80 deliveries for women with COVID-19, compared with 1 in 155 for those uninfected. Reported by NBC News, stillbirths were still indicated to be rare among the 1.2 million deliveries examined in 736 hospitals nationwide from March 2020 through September 2021, but risk was notably higher in women with COVID-19, particularly those infected with the Delta variant. Although the results do not prove that the variant caused more fetal demise, obstetricians are finding notable differences in how much oxygen fetuses can absorb depending on whether their mothers have been diagnosed with COVID-19.
Real-World Data Show Sotorasib Effective for NSCLC With KRAS Mutation
May 18th 2024Data from real-world and clinical-trial settings on frontline monotherapy treatment with the KRAS inhibitor sotorasib both show similar progression-free survivals and a high likelihood that the treatment’s efficacy is not affected with dose reduction.
Read More
Health Equity and Access Weekly Roundup: May 18, 2024
May 18th 2024The US Senate hosted a panel addressing physician and health care shortages and efforts to increase minority representation in the medical field. An expert discussed initiatives to prevent senior homelessness. Advocates called for the repeal of the Comstock Act. Regulatory reforms are called for to improve rural cancer patients' access to pharmacies. Research reveals the impact of denials on patient access to immunology treatments.
Read More
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen